193 related articles for article (PubMed ID: 11386325)
1. Trade systems in less-developed countries.
Nicholson J
Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386325
[No Abstract] [Full Text] [Related]
2. Trade systems in less-developed countries.
Kamal Smith M; 't Hoen E
Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324
[No Abstract] [Full Text] [Related]
3. Access to essential drugs.
Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
[No Abstract] [Full Text] [Related]
4. Medicines for all, not just the rich.
Davey S
Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
[No Abstract] [Full Text] [Related]
5. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
6. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
7. Free-trade agreements: challenges for global health.
Ribeiro H
Rev Saude Publica; 2015; 49():52. PubMed ID: 26270018
[TBL] [Abstract][Full Text] [Related]
8. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
9. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
10. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
11. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
12. Trade, TRIPS, and pharmaceuticals.
Smith RD; Correa C; Oh C
Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
[TBL] [Abstract][Full Text] [Related]
13. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
14. South Africa's moral victory.
Lancet; 2001 Apr; 357(9265):1303. PubMed ID: 11343727
[No Abstract] [Full Text] [Related]
15. Universal access to HIV/AIDS treatment: promise and problems.
Jaffe HW
JAMA; 2008 Aug; 300(5):573-5. PubMed ID: 18677030
[No Abstract] [Full Text] [Related]
16. Stemming the global trade in falsified and substandard medicines.
Gostin LO; Buckley GJ; Kelley PW
JAMA; 2013 Apr; 309(16):1693-4. PubMed ID: 23579391
[No Abstract] [Full Text] [Related]
17. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
Sawyer E
AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
[TBL] [Abstract][Full Text] [Related]
18. Affordable drugs for developing countries.
Chong CY
Hong Kong Med J; 2003 Apr; 9(2):148-9. PubMed ID: 12668831
[No Abstract] [Full Text] [Related]
19. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
20. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
[Next] [New Search]